SCHEMBL26034738

SCHEMBL26034738

CCc1ccc(NC(=O)c2ccc(C(F)(F)P)nc2C)cc1-c1cc(C)ccn1

nearest known ligand 0.53

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26034659 0.87 CYP2C9 (0.42) CYP2C9
SCHEMBL26033153 0.82 CYP2C9 (0.53) CYP2C9
SCHEMBL26034663 0.82 TRPV1 (0.40) CYP2C9
SCHEMBL26034650 0.81 CYP2C9 (0.40) CYP2C9
SCHEMBL2619534 0.81 CYP2C9 (0.51) CYP2C9
SCHEMBL1015520 0.81 CYP2C9 (0.63) CYP2C9
SCHEMBL26033648 0.77 CYP2C9 (0.48) CYP2C9
SCHEMBL1015265 0.76 CYP2C9 (0.57) CYP2C9
SCHEMBL26035955 0.76 ALB (0.46) CYP2C9
SCHEMBL12918406 0.73 ALB (0.46) CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230265054-A1 PYRIDYL INHIBITORS OF HEDGEHOG SIGNALLING GENENTECH, INC. (US) 2023-08-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230265054-A1 PYRIDYL INHIBITORS OF HEDGEHOG SIGNALLING SHH, GLI1, SMO CYP2C9 4725/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.